Chem Pharmacol 2012, 83:443?51. Li F, Rajendran P, Sethi G: Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human a number of myeloma cells through suppression of signal transducer and activator of transcription three activation pathway. Br J Pharmacol 2010, 161:541?54. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M: Thymoquinone inhibits tumor angiogenesis and tumor development via suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 2008, seven:1789?796. Das S, Dey KK, Dey G, Pal I, Majumder A, MaitiChoudhury S, Kundu SC, Mandal M: Antineoplastic and apoptotic potential of standard medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS A single 2012, seven:e46641. Gali-Muhtasib H, Ocker M, Kuester D, Krueger S, El-Hajj Z, Diestel A, Evert M, El-Najjar N, Peters B, Jurjus A, et al: Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer designs. J Cell Mol Med 2008, 12:330?42. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, Schneider-Stock R: Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells by way of a p53dependent mechanism. Int J Oncol 2004, 25:857?66. Dang CV: MYC within the path to cancer. Cell 2012, 149:22?5. Klaus A, Birchmeier W: Wnt signalling and its impact on advancement and cancer. Nat Rev Cancer 2008, 8:387?98.Lang et al. Molecular Cancer 2013, twelve:41 http://molecular-cancer/content/12/1/Page 13 of24. da Costa LT, He TC, Yu J, Sparks AB, Morin PJ, Polyak K, Laken S, Vogelstein B, Kinzler KW: CDX2 is mutated in a colorectal cancer with regular APC/ beta-catenin signaling. Oncogene 1999, 18:5010?014. 25. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B: Suppression of human colorectal carcinoma cell development by wild-type p53. Science 1990, 249:912?15. 26.Methyl aminolevulinate (hydrochloride) supplier Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE: The Fbw7 tumor suppressor regulates glycogen synthase kinase three phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004, 101:9085?090. 27. Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, Roessner A, Schneider-Stock R, Gali-Muhtasib H: Lack of p53 augments thymoquinoneinduced apoptosis and caspase activation in human osteosarcoma cells.(2-(Aminomethyl)phenyl)boronic acid manufacturer Cancer Biol Ther 2007, six:160?69.PMID:33485812 28. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA: Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer 2005, 117:409?17. 29. Gali-Muhtasib H, Kuester D, Mawrin C, Bajbouj K, Diestel A, Ocker M, Habold C, Foltzer-Jourdainne C, Schoenfeld P, Peters B, et al: Thymoquinone triggers inactivation of your worry response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res 2008, 68:5609?618. 30. Li Y, Bharti A, Chen D, Gong J, Kufe D: Interaction of glycogen synthase kinase 3beta using the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol 1998, 18:7216?224. 31. Houghton PJ, Zarka R, HB Dl, Hoult JR: Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995, 61:33?6. 32. Burits M, Bucar F: Antioxidant activity of Nigella sativa crucial oil. Phytother Res 2000, 14:323?28. 33. Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human scientific studies revisited. FA.